Aspire-Lakewood Holdings, Inc.
ASBP- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001847345
No open-market purchases or sales by Aspire-Lakewood Holdings, Inc. insiders were filed in the last 90 days; 13 institutions reported holding it in 13F filings for Q2 2026, worth $250.9K in total; no superinvestor holds it.
Other share classesASBPW
Q2 2023 vs. Q1 2023
How the institutions holding Aspire-Lakewood Holdings, Inc. changed between Q1 2023 and Q2 2023.
All holders in Q2 2023All holders in Q1 2023
| Measure | Q1 2023 | Q2 2023 | Change |
|---|---|---|---|
| Holders | 59 | 14 | −45 |
| Shares | 25.6M | 1.70M | −23.9M (−93.3%) |
| Value | $267.9M | $17.0M | −$250.9M (−93.6%) |
New holders (7)
Institutions that held Aspire-Lakewood Holdings, Inc. at the end of Q2 2023 but not at the end of Q1 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| P Schoenfeld Asset Management LP | 150,000 | $1.59M | 0.22% |
| Kepos Capital LP | 150,000 | $1.59M | 0.29% |
| Arena Investors LP | 150,000 | $1.57M | 1.52% |
| Exos TFP Holdings LLC | 150,000 | $1.56M | 0.77% |
| Sandia Investment Management LP | 150,000 | $1.56M | 0.49% |
| Fir Tree Capital Management LP | 67,089 | $703.1K | 0.07% |
| Robinson Capital Management, LLC | 3,235 | $33.7K | 0.01% |
Sold out (52)
Institutions that held Aspire-Lakewood Holdings, Inc. at the end of Q1 2023 and filed for Q2 2023 without it.